Skip to main content

Market Overview

UPDATE: Wunderlich Securities Reiterates on Physicians Realty Trust as Growth Capital is Deployed


In a report published Thursday, Wunderlich Securities analyst Merrill Ross reiterated a Buy rating on Physicians Realty Trust (NYSE: DOC), and raised the price target from $14.00 to $14.75.

In the report, Wunderlich Securities noted, “Buy-Rated Physicians Realty Trust (DOC) is our top pick among equity REITs for 2014, because we think the company has a long runway of accretive acquisition potential. The combination of an aging population, healthcare reform, and a shortage of doctors is changing the way medicine is practiced in the U.S. DOC works with doctors and hospital systems to monetize their facilities without disrupting their patient service. The company raised approximately $90mm by issuing 8.3mm shares on December 6, 2013 and expects to deploy the levered proceeds expeditiously to eliminate earnings dilution, and will maintain dividends at $0.90/sh in the mean time. Based on the post-acquisition stabilized earnings, we are raising our 12 month price target to $14.75.”

Physicians Realty Trust closed on Wednesday at $12.14.

Latest Ratings for DOC

Mar 2021Morgan StanleyUpgradesEqual-WeightOverweight
Jan 2021JefferiesUpgradesHoldBuy
Dec 2020KeyBancDowngradesOverweightSector Weight

View More Analyst Ratings for DOC
View the Latest Analyst Ratings


Related Articles (DOC)

View Comments and Join the Discussion!

Posted-In: Merrill Ross Wunderlich SecuritiesAnalyst Color Price Target Analyst Ratings

Latest Ratings

GIKColliers SecuritiesInitiates Coverage On14.0
SANWLake StreetInitiates Coverage On6.0
LILAMorgan StanleyDowngrades15.0
BEJP MorganUpgrades36.0
NEXACredit SuisseUpgrades11.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at